Sansure’s Cutting-Edge HPV Diagnostic Solutions
Sansure is committed to developing innovative in vitro diagnostics products that empower healthcare professionals in the fight against cervical cancer. Sansure’s Human Papillomavirus (HPV) DNA (23 genotypes) Diagnostic Kit is a prime example of their dedication to providing reliable and advanced testing capabilities.
Comprehensive HPV Genotyping for Personalized Care
This state-of-the-art diagnostic kit utilizes one-tube fast release technology and advanced magnetic beads to detect the presence of 23 high-risk HPV genotypes (Types 6, 11, 16, 18, 26, 31, 33, 35, 39, 42, 43, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, 81, 82) in exfoliated cervical cells. By identifying the specific HPV genotypes, healthcare providers can develop personalized management strategies for their patients, ensuring optimal care and early intervention where necessary.
Streamlined Workflow and Enhanced Sensitivity
Designed with efficiency in mind, the HPV DNA (23 genotypes) Diagnostic Kit features a streamlined workflow, with a total amplification time of just 70 minutes. Additionally, the kit boasts a high sensitivity of 400 copies/mL, enabling the detection of even low-level HPV infections. The inclusion of a β-globin gene internal control further ensures the reliability and accuracy of the test results.
Versatile Compatibility and CE Certification
Sansure’s HPV diagnostic solution is compatible with leading PCR instruments, including the Stratagene ABI7500, Life Technologies QuantStudio 5, and SLAN-96P, ensuring seamless integration into various laboratory settings. Furthermore, the kit is CE-marked, affirming its compliance with European Union regulatory standards and its suitability for use in clinical diagnostic applications.
Conclusion
By leveraging Sansure’s cutting-edge HPV diagnostic technology, healthcare professionals can enhance their cervical cancer screening programs, enabling earlier detection and more personalized treatment approaches. Together, Sansure is committed to advancing the fight against this preventable disease and improving the overall health and well-being of women worldwide.